MEMBERSHIP Mary Macdonald Prize and Bursary


The Mary Macdonald Prize for Achievement and Bursary were established in memory of former IBMS Council member Mary Macdonald. Mary is remembered as an outstanding professional, colleague and mentor, who began her career as a laboratory support worker and was keen to encourage and recognise excellence in others working in similar roles through this award. Mary made a significant contribution to the Institute throughout her life, serving as an IBMS Council member and on a number of IBMS committees.


Mary Macdonald Prize for Achievement Members who have been awarded their Certificate of Achievement Part II (CoA II) are eligible to be considered for the Mary Macdonald Prize for Achievement, which is awarded annually at the Institute’s AGM. The Prize of £100 is awarded following submission of a letter of recommendation from the manager and a statement from the candidate reflecting on how gaining the Certificate of Achievement Part II award would help them in their career. To enter, email your supporting


statements (supportstaff@ibms.org) or send by post to: Mary Macdonald Prize, IBMS, 12 Coldbath Square, London EC1R 5HL.


• The manager’s statement should include why it was felt that the person was suitable to undertake the qualification, the commitment they showed, and how they feel the candidate has benefitted.


The candidate’s statement is assessed against the following criteria: • Statement should be approximately 500 words


• The candidate outlines how completing the portfolio will help them in their career with respect to:


outlining how undertaking the Certificate of Achievement Part I or II will benefit the candidate’s practice and their wider team. The candidate’s statement is assessed


against the following criteria: • Statement should be approximately 500 words


• The candidate identifies the qualification they would use the bursary to pursue (Part I or II)


• The candidate demonstrates understanding of what the qualification is/involves


• The candidate outlines how completing the portfolio will benefit their practice


• The candidate outlines how completing the portfolio will benefit their workplace/team


The late Mary Macdonald.


• The learning they have undertaken to complete the portfolio


• Changes that may have occurred to their scope of practice as a direct result of completing the portfolio


• How these two elements have benefitted them professionally.


These must be submitted within three months of gaining the CoA II award. All entries received in one calendar year will be considered together by a panel, and the winner notified in the following April.


Mary Macdonald Bursary The Mary Macdonald Bursary is awarded to support candidates completing the IBMS Certificate of Achievement Part I or II. The bursary covers one year’s IBMS


Associate membership fee and the cost of the portfolio for candidates undertaking the IBMS Certificate of Achievement Part I or II. Candidates and their training officer


will both need to submit a supporting statement (maximum one side of A4)


• The candidate demonstrates understanding of the importance of continuing professional development/improvement.


To enter, submit both supporting statements by email (supportstaff@ibms.org) or send by post to: Mary Macdonald Prize, IBMS, 12 Coldbath Square, London EC1R 5HL. Please ensure that the applicant’s email address is included in the application.


The bursary is awarded quarterly, with deadlines of 11 January, 11 April, 11 July and 11 October.


All entries will be considered by a panel and successful candidate notified.


• Please note: Candidates cannot apply for the bursary to cover retrospectively the cost of an IBMS Certificate of Achievement Part I or II that has already been ordered, paid for or begun. The laboratory must hold current support staff training approval to receive the portfolio.


Reflective Learning Questions CELLULAR PATHOLOGY


Completion of reflective learning questions falls within the new 'Self-Directed Learning' category. The answers should be verified and signed off by the training officer/line manager/local CPD officer.


TRANSFUSION SCIENCE Q1 Discuss the clinical value of PD-1 and PD-L1 testing for the patient.


Q2 Discuss the steps you would take to ensure the adequate testing of the PD-1 and PD-L1 assay prior to clinical use in your department.


Q1 The Jra antigen was promoted from the 901 series of high-prevalence


antigens to a full blood group system in 2012. Outline, using the JR blood group system as an example, what is required by the International Society of Blood Transfusion (ISBT) Red Cell Immunogenetics and Blood Group Terminology Working Party for an antigen or a cluster of antigens to be declared a full blood group system.


Q2 What is the evidence that anti-Jra


haemolytic transfusion reaction, and how may a clinically significant haemolytic transfusion reaction caused by anti-Jra such a reaction does occur?


440


seldom causes a clinically significant be ameliorated when


AUGUST 2016 THE BIOMEDICAL SCIENTIST


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60